Maliha Sarfraz

Dr. Maliha Sarfraz


Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 January 2023 in Molecules
Verified
Journal Article
Open access
PDF file
SKShoaib Khan
Shoaib Khan
HUHayat Ullah
Hayat Ullah
MTMuhammad Taha
Muhammad Taha
DRDr. Fazal Rahim
Dr. Fazal Rahim
MSMaliha Sarfraz
Maliha Sarfraz
WVWolfgang Voelter
Wolfgang Voelter
Alzheimer’s disease is a major public brain condition that has resulted in many deaths, as revealed by the World Health Organization (WHO). Conventional Alzheimer’s treatments such as chemotherapy, surgery, and radiotherapy are not very effective and are usually associated with several adverse effects. Therefore, it is necessary to find a new therapeutic approach that completely treats Alzheimer’s disease without many side effects. In this research project, we report the synthesis and biological activities of some new thiazole-bearing sulfonamide analogs (1–21) as potent anti-Alzheimer’s agents. Suitable characterization techniques were employed, and the density functional theory (DFT) computational approach, as well as in-silico molecular modeling, has been employed to assess the electronic properties and anti-Alzheimer’s potency of the analogs. All analogs exhibited a varied degree of inhibitory potential, but analog 1 was found to have excellent potency (IC50 = 0.10 ± 0.05 µM for AChE) and (IC50 = 0.20 ± 0.050 µM for BuChE) as compared to the reference drug donepezil (IC50 = 2.16 ± 0.12 µM and 4.5 ± 0.11 µM). The structure-activity relationship was established, and it mainly depends upon the nature, position, number, and electron-donating/-withdrawing effects of the substituent/s on the phenyl rings.

18 September 2022 in Molecules
Verified
Journal Article
Open access
PDF file
RHRafaqat Hussain
Rafaqat Hussain
HUHayat Ullah
Hayat Ullah
DRDr. Fazal Rahim
Dr. Fazal Rahim
MSMaliha Sarfraz
Maliha Sarfraz
MTMuhammad Taha
Muhammad Taha
MAMahmoud Ali Abdelaziz
Mahmoud Ali Abdelaziz
Twenty-four analogues of benzimidazole-based thiazoles (1–24) were synthesized and assessed for their in vitro acetylcholinesterase (AChE) and butyrylcholinesterase (BuChE) inhibitory potential. All analogues were found to exhibit good inhibitory potential against cholinesterase enzymes, having IC50 values in the ranges of 0.10 ± 0.05 to 11.10 ± 0.30 µM (for AChE) and 0.20 ± 0.050 µM to 14.20 ± 0.10 µM (for BuChE) as compared to the standard drug Donepezil (IC50 = 2.16 ± 0.12 and 4.5 ± 0.11 µM, respectively). Among the series, analogues 16 and 21 were found to be the most potent inhibitors of AChE and BuChE enzymes. The number (s), types, electron-donating or -withdrawing effects and position of the substituent(s) on the both phenyl rings B & C were the primary determinants of the structure-activity relationship (SAR). In order to understand how the most active derivatives interact with the amino acids in the active site of the enzyme, molecular docking studies were conducted. The results obtained supported the experimental data. Additionally, the structures of all newly synthesized compounds were elucidated by using several spectroscopic methods like 13C-NMR, 1H-NMR and HR EIMS.

20 December 2022 in Molecules
Verified
Journal Article
Open access
PDF file
DRDr. Fazal Rahim
Dr. Fazal Rahim
HUHayat Ullah
Hayat Ullah
MTMuhammad Taha
Muhammad Taha
RHRafaqat Hussain
Rafaqat Hussain
MSMaliha Sarfraz
Maliha Sarfraz
WVWolfgang Voelter
Wolfgang Voelter
Triazole-based thiosemicarbazone derivatives (6a–u) were synthesized then characterized by spectroscopic techniques, such as 1HNMR and 13CNMR and HRMS (ESI). Newly synthesized derivatives were screened in vitro for inhibitory activity against acetylcholinesterase (AChE) and butyrylcholinesterase (BuChE) enzymes. All derivatives (except 6c and 6d, which were found to be completely inactive) demonstrated moderate to good inhibitory effects ranging from 0.10 ± 0.050 to 12.20 ± 0.30 µM (for AChE) and 0.20 ± 0.10 to 14.10 ± 0.40 µM (for BuChE). The analogue 6i (IC50 = 0.10 ± 0.050 for AChE and IC50 = 0.20 ± 0.050 µM for BuChE), which had di-substitutions (2-nitro, 3-hydroxy groups) at ring B and tri-substitutions (2-nitro, 4,5-dichloro groups) at ring C, and analogue 6b (IC50 = 0.20 ± 0.10 µM for AChE and IC50 = 0.30 ± 0.10 µM for BuChE), which had di-Cl at 4,5, -NO2 groups at 2-position of phenyl ring B and hydroxy group at ortho-position of phenyl ring C, emerged as the most potent inhibitors of both targeted enzymes (AChE and BuChE) among the current series. A structure-activity relationship (SAR) was developed based on nature, position, number, electron donating/withdrawing effects of substitution/s on phenyl rings. Molecular docking studies were used to describe binding interactions of the most active inhibitors with active sites of AChE and BuChE.

11 August 2015 in Frontiers in Chemistry
Verified
Journal Article
Open access
PDF file
MAMuhammad Aqeel Ashraf
Muhammad Aqeel Ashraf
AKAysha Masood Khan
Aysha Masood Khan
PAProfessor Dr Mushtaq Ahmad
Professor Dr Mushtaq Ahmad
MSMaliha Sarfraz
Maliha Sarfraz
Microencapsulation has become a hot topic in chemical research. Technology mainly used for control release and protection purposes. The sol–gel micro encapsulation approach for fragrance and aroma in porous silica-based materials leads to sustainable odorant and flavored materials with novel and unique beneficial properties. Sol-gel encapsulation of silica based micro particles considered economically cheap as capital investment in manufacturing is very low and environmentally friendly. Amorphous sol–gel SiO2 is non-toxic and safe, whereas the sol–gel entrapment of delicate chemicals in its inner pores results in pronounced chemical and physical stabilization of the entrapped actives, thereby broadening the practical utilization of chemically unstable essential oils. Reviewing progress in the fabrication of diverse odorant and flavoured sol-gels, shows us how different synthetic strategies are appropriate for practical application with important health and environmental benefits.

15 October 2022 in Molecules
Verified
Journal Article
Open access
PDF file
HUHayat Ullah
Hayat Ullah
SKShoaib Khan
Shoaib Khan
DRDr. Fazal Rahim
Dr. Fazal Rahim
MTMuhammad Taha
Muhammad Taha
RIRashid Iqbal
Rashid Iqbal
IJIbrahim Jafri
Ibrahim Jafri
Diabetes mellitus is one of the most chronic metabolic diseases. In the past few years, our research group has synthesized and evaluated libraries of heterocyclic analogs against α-glucosidase and α-amylase enzymes and found encouraging results. The current study comprises the evaluation of benzimidazole-bearing thiosemicarbazone as antidiabetic agents. A library of fifteen derivatives (7–21) was synthesized, characterized via different spectroscopic techniques such as HREI-MS, NMR, and screened against α-glucosidase and α-amylase enzymes. All derivatives exhibited excellent to good biological inhibitory potentials. Derivatives 19 (IC50 = 1.30 ± 0.20 µM and 1.20 ± 0.20 µM) and 20 (IC50 = 1.60 ± 0.20 µM and 1.10 ± 0.01 µM) were found to be the most potent among the series when compared with standard drug acarbose (IC50 = 11.29 ± 0.07 and 11.12 ± 0.15 µM, respectively). These derivatives may potentially serve as the lead candidates for the development of new therapeutic representatives. The structure–activity relationship was carried out for all molecules which are mainly based upon the pattern of substituent/s on phenyl rings. Moreover, in silico docking studies were carried out to investigate the active binding mode of selected derivatives with the target enzymes.

1 March 2016 in Desalination and Water Treatment
Verified
Journal Article
Open access
FMFaryal Mateen
Faryal Mateen
IJIqra Javed
Iqra Javed
URUzaira Rafique
Uzaira Rafique
NTNoshaba Tabassum
Noshaba Tabassum
MSMaliha Sarfraz
Maliha Sarfraz
MAMuhammad Aqeel Ashraf
Muhammad Aqeel Ashraf
Rapid development of civilization together with the evolution of industry has caused deep changes in the quality of the environment in which the human beings live. The enhancing demands for a healthy environment, particularly for the removal of pollutants from industrial and municipal wastewater, are a major reason to search for new materials. Zeolites are potential materials and can conveniently be used as adsorbents for the removal of environmental pollutants. The present research offers a green approach to investigate the removal efficiency of polyaromatic hydrocarbons and azo dyes from wastewater using zeolite derived from incinerator waste (ash) as an effective, economical, and environmentlly friendly suitable material as an adsorbent. The significance rests on the use of hazardous waste into a useful resource (adsorbent). Batch adsorption studies are conducted and results are analyzed by UV–vis spectrophotometer. The results depicted the performance of zeolite incinerator ash (1 mg/kg) in removing 98, 97, and 96% of anthracene, phenanthrene, and pyrene, respectively, and up to 90% removal of the dyes upon adsorbate–adsorbent contact for 10 min. Thus, the zeolite made from natural waste materials possess unique porous properties and offer promise for the removal of organic pollutants. The recovery ability can also be tested and evaluated to determine the reusability of the adsorbent. This is an additional benefit which reduces the need for extracting materials from the environment to be used in the industrial processes.